CClinicalTrials.gg
Not yet recruitingNCT07866027VAP-MLUpdated Oct 8, 2026

Mobile-Based Microlearning for Improving ICU Nurses' Adherence to Ventilator-Associated Pneumonia Prevention Protocols

An interventional study of Mobile-Based Microlearning Program and Routine Education in Ventilator-Associated Pneumonia, sponsored by Alexandria University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Alexandria University · Not applicable, Interventional, and Supportive care

Updated Oct 8, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Ventilator-associated pneumonia (VAP) is one of the most common healthcare-associated infections among mechanically ventilated patients and is associated with increased morbidity, mortality, length of intensive care unit stay, and healthcare costs. Adherence of intensive care unit (ICU) nurses to evidence-based VAP prevention protocols is essential for reducing the incidence of VAP; however, maintaining consistent adherence remains challenging.

This randomized controlled trial aims to evaluate the effectiveness of a mobile-based microlearning educational program in improving ICU nurses' adherence to VAP prevention protocols. Eligible ICU nurses will be randomly assigned to either an intervention group receiving a mobile-based microlearning program or a control group receiving routine educational resources. The microlearning program will deliver short, focused learning modules through mobile devices using multimedia content, interactive activities, reminders, and reinforcement strategies.

The primary outcome is nurses' adherence to VAP prevention practices. Secondary outcomes include nurses' knowledge regarding VAP prevention and knowledge retention over time. Findings from this study may support the integration of mobile-based microlearning approaches into continuing nursing education programs to enhance evidence-based practice in critical care settings.

02

Conditions studied

  • Ventilator-Associated Pneumonia

Keywords

  • Ventilator-Associated Pneumonia Prevention
03

In context

Pneumonia, Ventilator-Associated

392 studies on the registry are indexed under Pneumonia, Ventilator-Associated; 81 are open to participants now.

This study's planned enrollment of 110 is close to the median of 122 across 254 interventional studies indexed under Pneumonia, Ventilator-Associated.

Browse Pneumonia, Ventilator-Associated studies →

Lead sponsor

Alexandria University is the lead sponsor of 570 studies on the registry; 126 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Registered nurses working in adult intensive care units.
  • Providing direct care to mechanically ventilated patients.
  • Having at least 6 months of ICU clinical experience.
  • Able to read and understand English.
  • Owning a smartphone with internet access.
  • Willing to participate and provide informed consent.

Exclusion criteria

Exclusion Criteria:

  • Nurses on leave during the study period.
  • Administrative nurses who do not provide direct patient care.
  • Nurses who previously received structured training on the study microlearning program.
  • Nurses who decline participation or withdraw from the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
110 participants (estimated)

Study arms

  • Experimental
    Mobile-Based Microlearning Group

    Participants will receive a structured mobile-based microlearning program focused on evidence-based ventilator-associated pneumonia prevention practices. Educational content will be delivered through mobile devices using short learning modules, multimedia materials, quizzes, reminders, and reinforcement activities.

    Behavioral: Mobile-Based Microlearning Program

  • Active comparator
    Routine Education Group

    Participants will receive routine educational resources and standard institutional training regarding ventilator-associated pneumonia prevention practices.

    Other: Routine Education

Interventions

  • BehavioralMobile-Based Microlearning Program

    A mobile-based educational intervention consisting of short learning modules addressing evidence-based ventilator-associated pneumonia prevention measures, including hand hygiene, oral care, head-of-bed elevation, suctioning practices, ventilator care, and adherence to VAP prevention bundles.

  • OtherRoutine Education

    Standard educational materials and routine institutional education related to ventilator-associated pneumonia prevention practices.

06

What researchers measure

Primary outcomes

  1. ICU Nurses' Adherence to Ventilator-Associated Pneumonia Prevention Protocols

    Adherence to ventilator-associated pneumonia prevention protocols measured using a structured observational checklist. Higher scores indicate better adherence to evidence-based VAP preventive practices.

    Time frame: Baseline, 4 weeks post-intervention, and 8 weeks follow-up

Secondary outcomes

  1. ICU Nurses' Knowledge Regarding Ventilator-Associated Pneumonia Prevention

    Knowledge regarding ventilator-associated pneumonia prevention measured using a structured knowledge questionnaire. Higher scores indicate greater knowledge.

    Time frame: Baseline, 4 weeks post-intervention, and 8 weeks follow-up

07

Study locations

1 site
  • Faculty of Nursing, Alexandria University
    Alexandria, 21511, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07866027
Lead sponsor
Alexandria University
Responsible party
Mohamed Fakhry Ahmed Salem (dr, Alexandria University) — Principal investigator
First posted
Oct 8, 2026
Start date
Oct 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 8, 2026

Study contacts

Mohamed Fakhry Salem, PhD
Contact
Mohamed.Fakhry@alexu.edu.eg
01286038014
Mohamed Salem, PHD
principal investigator · Alexandria University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion